– External device uses heart sound and AI to deliver rapid cardiac function assessments via tablet to expand hemodynamic evaluation beyond the Cath lab – LOS ANGELES–(BUSINESS WIRE)–Sensydia, an innovator in rapid, non-invasive measurement of critical cardiac function, today announced that its Cardiac Performance System (CPSTM) has been granted Breakthrough Device Designation by the […]
Other News
Acutus Medical Announces Restructuring and Preliminary, Unaudited Fourth Quarter and Full Year 2021 Revenue
CARLSBAD, Calif., Jan. 19, 2022 (GLOBE NEWSWIRE) — Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today announced a corporate restructuring as well as its preliminary unaudited revenue for the quarter and full year […]
DR. JEREMY DURACK AND DR. JOHN SIMPSON TO JOIN CORDIS-X INNOVATION ACCELERATOR
MENLO PARK, Calif., Jan. 18, 2022 /PRNewswire/ — Ajax Health has announced the appointments of two of the most respected cardiovascular professionals to Cordis-X, an independent accelerator created to drive innovation and growth to Cordis. Cordis is a storied medical device brand with global reach that was acquired from Cardinal Health last […]
GORE® CARDIOFORM Septal Occluder Marks 10 Years of Improving Lives
After a decade of clinical use* and more than 50,000 devices sold globally, the GORE® CARDIOFORM Septal Occluder continues a trusted legacy of safely advancing care. FLAGSTAFF, Ariz., Jan. 19, 2022 /PRNewswire/ — W. L. Gore & Associates (Gore) today announced that the GORE® CARDIOFORM Septal Occluder has achieved 10 years of clinical […]
Peijia Medical Obtained Exclusive License for JenaValve’s Trilogy TAVR System for Treating AR in the Greater China Region
SUZHOU, China, Jan. 19, 2022 /PRNewswire/ — Peijia Medical Limited (HKEX: 9996) is pleased to announce its strategic investment and exclusive in-licensing agreement with JenaValve Technology, Inc. Under the terms of the agreement, Peijia has made a cash and equity investment in JenaValve and will commit additional capital based upon development milestones in […]
HeartFlow Appoints Timothy Barabe to its Board of Directors
REDWOOD CITY, Calif., Jan. 18, 2022 (GLOBE NEWSWIRE) — HeartFlow Holding, Inc., the leader in revolutionizing precision heart care, today announced the appointment of Timothy Barabe to its Board of Directors. “We are honored to have an accomplished leader like Tim join the HeartFlow Board,” said William C. Weldon, Chairman of […]
Stanford Health Care Selects HeartVista’s MRI Automation Platform to Deliver Rapid, AI-Powered Cardiac Scans
Initial three-year software-as-a-service agreement will enable Stanford Health Care to deploy AI-powered cardiac MRI scans with Siemens Healthineers and GE Healthcare MRI machines AI technology produces diagnostic-level images quickly and efficiently while also increasing CMR throughput PALO ALTO, Calif.–(BUSINESS WIRE)–HeartVista, a pioneer in AI-powered MRI solutions, today announced that it […]
InspireMD Announces Live Case Broadcast at ISET 2022 Conference Following the Supplement Approval by the FDA Regarding its Pivotal C-Guardians Trial
Live Case will be Broadcasted Today at 11:00am ET TEL AVIV, Israel, Jan. 18, 2022 (GLOBE NEWSWIRE) — InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention Stent System (EPS) for prevention of stroke caused by Carotid Artery Disease (CAD), today announced that a live case demonstration featuring CGuard™ […]
UH Harrington Heart & Vascular Institute Limb Salvage Advisory Council Diverts Patients from Amputation and Improves Outcomes
Findings published in American Heart Association’s Circulation: Cardiovascular Interventions CLEVELAND – Findings from a first-of-its-kind study conducted at University Hospitals (UH) Harrington Heart & Vascular Institute showed a novel system-wide interdisciplinary team assembled to evaluate alternative treatments to major amputation improved outcomes for patients with Critical Limb-Threatening Ischemia (CLTI). […]
CryoLife Announces Corporate Rebranding and Changes Name to Artivion
Artivion to Host Investor & Analyst Day on March 23, 2022 ATLANTA, Jan. 18, 2022 /PRNewswire/ — CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it was renaming and rebranding itself to Artivion, Inc., effective immediately. Derived from the words “aorta”, “innovation”, and […]



